MOH Molina Healthcare Inc Common Stock
NYSE · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Jul 23, 2026MOH Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
MOH Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
| Ex-Datum | Split | Typ |
|---|---|---|
| 23. Mai 2011 | 3-for-2 | Vorwärts |
Über Molina Healthcare Inc Common Stock Unternehmensübersicht von Wikipedia
Die Molina Healthcare, Inc. ist ein US-amerikanisches Gesundheits- und Versicherungsunternehmen mit Hauptsitz in Long Beach im Bundesstaat Kalifornien. Das Unternehmen ist auf die Bereitstellung von Gesundheitsdienstleistungen und Krankenversicherungen für einkommensschwächere Bevölkerungsgruppen spezialisiert, insbesondere im Rahmen staatlicher Programme wie Medicaid und Medicare. Molina Healthcare gehört zu den größten Anbietern von Managed-Care-Dienstleistungen in den Vereinigten Staaten. Ende 2024 betreute das Unternehmen knapp 5,5 Millionen Menschen.
Geschichte
Molina Healthcare wurde 1980 von dem Arzt C. David Molina gegründet. Ausgangspunkt war eine Klinik in Long Beach, die vor allem einkommensschwache Patienten behandelte. Ziel war es, medizinische Versorgung für Bevölkerungsgruppen zugänglich zu machen, die häufig nur begrenzten Zugang zum Gesundheitssystem hatten. Molina gründete seine erste Hausarztpraxis mit dem Ziel, Patienten mit dem geringsten Einkommen zu behandeln, unabhängig von ihrer Zahlungsfähigkeit. In den 1980er und 1990er Jahren entwickelte sich das Unternehmen von einem lokalen Gesundheitsanbieter zu einem Managed-Care-Unternehmen, das mit staatlichen Programmen zusammenarbeitete. Molina begann, Verträge mit Bundesstaaten abzuschließen, um Gesundheitsdienstleistungen im Rahmen von Medicaid bereitzustellen. Die Expansion über Kalifornien heraus begann Ende der 1990er Jahre.
Molina Healthcare reichte im Dezember 2002 bei der Securities and Exchange Commission einen Antrag auf einen Börsengang ein und ging im Juli 2003 mit einem Emissionsvolumen von 102 Millionen US-Dollar an die Börse. Der Ausgabepreis der Aktien betrug 17,50 US-Dollar, und Molina nahm bei dem Börsengang rund 124 Millionen US-Dollar ein. Molina Healthcare stieg 2006 in den Medicare-Markt ein. Im Jahr 2014 begann Molina Healthcare damit, Marketplace-Tarife in neun Bundesstaaten anzubieten, in denen das Unternehmen Medicaid-Krankenversicherungstarife über staatlich verwaltete Marktplätze und den bundesweit verwalteten Marktplatz anbot. Am 16. November 2016 berichtete die Seattle Times, dass etwa 11 Millionen Menschen ihren Versicherungsschutz über den Marktplatz erhalten.
Molina Healthcare übernahm im Dezember 2010 den Geschäftsbereich Gesundheitsinformationsmanagement von Unisys und gründete damit Molina Medicaid Solutions (MMS). Im Herbst 2018 verkaufte Molina Healthcare, Inc. sein Geschäftsfeld für Medicaid-Management-Informationssysteme, Molina Medicaid Solutions (MMS), an DXC Technology. Zum Zeitpunkt des Verkaufs war MMS eine hundertprozentige Tochtergesellschaft von Molina Healthcare. Im September 2020 verkündete Molina Healthcare eine Vereinbarung über den Erwerb nahezu aller Vermögenswerte von Affinity Health Plan für rund 380 Millionen US-Dollar.
Geschäftsmodell
Das Geschäftsmodell von Molina Healthcare basiert auf sogenannten '''Managed-Care-Verträgen''' mit staatlichen Stellen, mit einem Fokus auf einkommensschwächere Gruppen. Dabei erhält das Unternehmen feste Zahlungen pro versicherter Person und organisiert im Gegenzug die medizinische Versorgung. Dieses Modell soll Kosten kontrollieren und gleichzeitig die Qualität der Versorgung verbessern. Molina setzt dabei auf Netzwerke von Gesundheitsdienstleistern sowie auf Programme zur Prävention und Koordination von Behandlungen. 2022 kamen knapp 80 Prozent der Beitragseinnahmen von Molina aus dem Programm Medicaid, 12 Prozent aus dem Programm Medicare und 8 Prozent vom Marketplace. Das Unternehmen betreibt selbst mehr als 20 Kliniken landesweit, wo Grundversorgung angeboten wird.
== Einzelnachweise ==
Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | MOH | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | 1053.05-Jahres-Durchschnitt ≈21.1 | ≈21.1 | 36.3 | Überbewertet | |
| P/S (TTM) | 0.25-Jahres-Durchschnitt ≈0.5 | ≈0.5 | 0.7 | Unterbewertet | |
| K/B (MRQ) | 2.45-Jahres-Durchschnitt ≈4.3 | ≈4.3 | 3.9 | Unterbewertet | |
| EV / EBITDA (TTM) | 12.75-Jahres-Durchschnitt ≈7.0 | ≈7.0 | 16.1 | Unterbewertet | |
| Kurs / FCF (TTM) | 36.45-Jahres-Durchschnitt ≈14.4 | ≈14.4 | · | · | |
| Kurs / Cashflow (TTM) | 27.05-Jahres-Durchschnitt ≈11.5 | ≈11.5 | · | · | |
| EV / Umsatz (TTM) | 0.15-Jahres-Durchschnitt ≈0.3 | ≈0.3 | · | · | |
| EV / FCF (TTM) | 17.45-Jahres-Durchschnitt ≈10.3 | ≈10.3 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 5.35-Jahres-Durchschnitt ≈7.7 | ≈7.7 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | MOH | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | 0.46%5-Jahres-Durchschnitt ≈3.6% | ≈3.6% | 3.5% | Schwach | |
| EBITDA-Marge (TTM) | 0.83%5-Jahres-Durchschnitt ≈4.1% | ≈4.1% | 3.7% | Schwach | |
| Vorgewinnmarge (TTM) | -0.01%5-Jahres-Durchschnitt ≈3.2% | ≈3.2% | 2.8% | Schwach | |
| Nettogewinnmarge (TTM) | -0.02%5-Jahres-Durchschnitt ≈2.4% | ≈2.4% | 2.9% | Schwach | |
| ROA (TTM) | -0.04%5-Jahres-Durchschnitt ≈6.3% | ≈6.3% | 3.0% | Im Einklang | |
| ROE (TTM) | -0.16%5-Jahres-Durchschnitt ≈23.1% | ≈23.1% | 10.1% | Im Einklang | |
| ROIC | 8.0%5-Jahres-Durchschnitt ≈15.3% | ≈15.3% | 8.0% | Im Einklang |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | MOH | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 0.95-Jahres-Durchschnitt ≈0.7 | ≈0.7 | 0.7 | Hohe Verschuldung | |
| Liquiditätsgrad (MRQ) | 1.75-Jahres-Durchschnitt ≈1.5 | ≈1.5 | 1.7 | Im Einklang | |
| Quick Ratio (MRQ) | 1.65-Jahres-Durchschnitt ≈1.5 | ≈1.5 | 1.3 | Starke Liquidität | |
| Langfristige Schulden / Eigenkapital (MRQ) | 0.95-Jahres-Durchschnitt ≈0.7 | ≈0.7 | 0.7 | Hohe Verschuldung |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | MOH | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 11.8%5-Jahres-Durchschnitt ≈19.1% | ≈19.1% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 12.4%5-Jahres-Durchschnitt ≈15.5% | ≈15.5% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 18.5% | · | · | · | |
| EPS YoY (EPS VjV) | -56.3%5-Jahres-Durchschnitt ≈2.3% | ≈2.3% | · | · | |
| Net Income YoY (Nettogewinn YoY) | -60.0%5-Jahres-Durchschnitt ≈0.79% | ≈0.79% | · | · | |
| EPS CAGR 3Y (EPS CAGR 3J) | -13.0%5-Jahres-Durchschnitt ≈9.2% | ≈9.2% | · | · | |
| EPS CAGR 5Y (EPS CAGR 5J) | -4.5% | · | · | · | |
| Net Income CAGR 3Y (Nettoergebnis CAGR 3J) | -15.8%5-Jahres-Durchschnitt ≈7.7% | ≈7.7% | · | · | |
| Net Income CAGR 5Y (Nettoergebnis CAGR 5J) | -6.9% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | MOH | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 2.95-Jahres-Durchschnitt ≈2.6 | ≈2.6 | 2.4 | Spitzenklasse | |
| Receivables Turnover (Forderungsumschlag) | 13.35-Jahres-Durchschnitt ≈13.5 | ≈13.5 | 16.3 | Unterdurchschnittlich | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$2.4M | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Jul 21, 2026 | $1.51 | $1.40 | 7.5% |
| 31. März 2026 | $2.35 | $1.94 | 21.0% | |
| 31. Dezember 2025 | $-2.75 | $0.34 | -916.0% | |
| 30. September 2025 | $1.84 | $3.94 | -53.3% | |
| 30. Juni 2025 | $5.48 | $5.85 | -6.3% | |
| 31. März 2025 | $6.08 | $6.02 | 1.1% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $45.43B | $40.65B | $34.07B | $31.97B | $27.77B | $19.42B | $16.83B | $18.89B | $19.88B | $17.78B | $14.18B | $9.67B | |
| Cost of Revenue | $39.49B | $34.43B | $28.67B | $27.18B | $23.70B | $15.82B | $13.90B | · | · | · | · | · | |
| Gross Profit | · | · | · | · | · | $2.48B | $2.30B | $2.52B | $1.81B | $1.73B | $1.53B | $1.00B | |
| SG&A Expense | $3.01B | $2.74B | $2.46B | $2.31B | $2.07B | $1.48B | $1.30B | $1.33B | $1.59B | $1.39B | $1.15B | $765M | |
| Operating Expenses | $44.65B | $38.94B | $32.50B | $30.80B | $26.75B | $18.34B | $15.79B | $17.76B | $20.44B | $17.48B | $13.79B | $9.47B | |
| Operating Income | $781M | $1.71B | $1.57B | $1.17B | $1.02B | $1.08B | $1.04B | $1.13B | $-555M | $306M | $387M | $193M | |
| Interest Expense | · | · | $109M | $110M | $120M | $102M | $87M | $115M | $118M | $101M | $66M | $57M | |
| Interest Income | · | · | · | $75M | $77M | $17M | $17M | $125M | $70M | $38M | $23M | $20M | |
| Other Non-op | · | · | $0 | $0 | $-25M | $-15M | $15M | $-17M | $61M | $0 | $1M | $-1M | |
| Pretax Income | $589M | $1.59B | $1.46B | $1.06B | $875M | $961M | $972M | $999M | $-612M | $205M | $322M | $135M | |
| Income Tax | $117M | $410M | $373M | $271M | $216M | $288M | $235M | $292M | $-100M | $153M | $179M | $73M | |
| Net Income | $472M | $1.18B | $1.09B | $792M | $659M | $673M | $737M | $707M | $-512M | $52M | $143M | $62M | |
| EPS (Basic) | $8.93 | $20.52 | $18.91 | $13.72 | $11.40 | $11.40 | $11.85 | $11.57 | $-9.07 | $0.93 | $2.75 | $1.33 | |
| EPS (Diluted) | $8.92 | $20.42 | $18.77 | $13.55 | $11.25 | $11.23 | $11.47 | $10.61 | $-9.07 | $0.92 | $2.58 | $1.29 | |
| Shares (Basic) | 52,800,000 | 57,400,000 | 57,700,000 | 57,800,000 | 57,800,000 | 59,000,000 | 62,200,000 | 61,000,000 | 56,000,000 | 55,400,000 | 52,000,000 | 47,000,000 | |
| Shares (Diluted) | 52,900,000 | 57,700,000 | 58,100,000 | 58,500,000 | 58,600,000 | 59,900,000 | 64,200,000 | 67,000,000 | 56,000,000 | 56,000,000 | 56,000,000 | 48,000,000 | |
| EBITDA | $976M | $1.89B | $1.74B | $1.35B | $1.15B | $1.17B | $1.13B | $1.26B | $-377M | $488M | $513M | $327M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.25B | $4.66B | $4.85B | $4.01B | $4.44B | $4.15B | $2.45B | $2.83B | $3.19B | $2.82B | $2.33B | $1.54B | |
| Short-term Investments | $4.01B | $4.33B | $4.26B | $3.50B | $3.20B | $1.88B | $1.95B | $1.68B | $2.52B | $1.76B | $1.80B | $1.02B | |
| Receivables | $3.53B | $3.30B | $3.10B | $2.30B | $2.18B | $1.67B | $1.41B | $1.33B | $871M | $974M | $597M | $596M | |
| Prepaid Expense | $655M | $487M | $331M | $277M | $247M | $175M | $163M | $149M | $239M | $131M | $192M | $49M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $51M | |
| Current Assets | $12.44B | $12.77B | $12.54B | $10.08B | $10.06B | $7.88B | $5.97B | $6.46B | $7.51B | $5.99B | $5.31B | $3.20B | |
| PP&E (Net) | · | · | · | · | · | · | · | $241M | $342M | $454M | $393M | $341M | |
| PP&E (Gross) | $1.11B | $1.03B | $932M | $882M | $822M | $752M | $687M | $774M | $883M | $919M | $755M | $618M | |
| Accum. Depreciation | $875M | $806M | $729M | $695M | $632M | $577M | $530M | $533M | $541M | $465M | $362M | $277M | |
| Goodwill | $1.96B | $1.67B | $1.24B | $1.11B | $982M | $692M | $143M | $143M | $186M | $620M | $519M | $272M | |
| Intangibles | $237M | $267M | $208M | $275M | $270M | $249M | $29M | $47M | $69M | $140M | $122M | $89M | |
| Other Non-current Assets | $147M | $138M | $143M | $123M | $179M | $119M | $105M | $24M | $141M | $41M | $28M | $30M | |
| Total Assets | $15.56B | $15.63B | $14.89B | $12.31B | $12.21B | $9.53B | $6.79B | $7.15B | $8.47B | $7.45B | $6.58B | $4.43B | |
| Accounts Payable | $1.09B | $1.33B | $1.25B | $889M | $842M | $641M | $502M | $390M | $366M | $385M | $362M | $242M | |
| Current Liabilities | $7.37B | $7.90B | $8.17B | $6.86B | $7.05B | $4.96B | $3.27B | $4.25B | $5.56B | $4.57B | $3.82B | $2.17B | |
| Capital Leases | $56M | $68M | $85M | $77M | $99M | $42M | $48M | $197M | $198M | $198M | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | $0 | $15M | $0 | $24M | |
| Other Non-current Liabilities | $173M | $120M | $124M | $104M | $140M | $119M | $90M | $44M | $61M | $42M | $37M | $34M | |
| Total Liabilities | $11.49B | $11.13B | $10.68B | $9.35B | $9.58B | $7.44B | $4.83B | $5.51B | $7.13B | $5.80B | $5.02B | $3.42B | |
| Long-term Debt | · | · | · | · | · | $2.13B | $1.25B | · | · | $1.65B | $1.41B | $690M | |
| Total Debt | $3.77B | $2.92B | $2.18B | $2.18B | $2.17B | $2.13B | $1.24B | $1.02B | $1.32B | $1.65B | $449M | $341.0K | |
| Retained Earnings | $3.60B | $4.09B | $3.89B | $2.80B | $2.40B | $1.86B | $1.78B | $1.01B | $298M | $810M | $758M | $615M | |
| AOCI | $15M | $-57M | $-82M | $-160M | $-5M | $37M | $4M | $-8M | $-5M | $-2M | $-4M | $-1M | |
| Stockholders' Equity | $4.07B | $4.50B | $4.21B | $2.96B | $2.63B | $2.10B | $1.96B | $1.65B | $1.34B | $1.65B | $1.56B | $1.01B | |
| Liabilities + Equity | $15.56B | $15.63B | $14.89B | $12.31B | $12.21B | $9.53B | $6.79B | $7.15B | $8.47B | $7.45B | $6.58B | $4.43B | |
| Shares Outstanding | 51,000,000 | 56,000,000 | 58,000,000 | 58,000,000 | 58,000,000 | 59,000,000 | 62,000,000 | 62,000,000 | 60,000,000 | 57,000,000 | 56,000,000 | 50,000,000 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $195M | $186M | $171M | $176M | $131M | $88M | $89M | $127M | $178M | $182M | $126M | $134M | |
| Stock-based Comp | $47M | $116M | $115M | $103M | $72M | $57M | $39M | $27M | $46M | $26M | $23M | $22M | |
| Deferred Tax | $43M | $53M | $-31M | $-66M | $-24M | $-19M | $10M | $-6M | $-94M | $22M | $-7M | $-2M | |
| Amort. of Intangibles | $91M | $82M | $85M | $77M | $49M | $15M | $18M | $21M | $31M | $32M | $17M | $18M | |
| Restructuring | · | · | · | · | · | · | · | $8M | $150M | · | · | · | |
| Other Non-cash | $-1.29B | $-890M | $316M | $-232M | $1.28B | $1.09B | $-448M | $-1.17B | $1.19B | $391M | $840M | $844M | |
| Operating Cash Flow | $-535M | $644M | $1.66B | $773M | $2.12B | $1.90B | $434M | $-314M | $804M | $673M | $1.12B | $1.06B | |
| CapEx | $101M | $100M | $84M | $91M | $77M | $74M | $57M | $30M | $86M | $176M | $132M | $115M | |
| Investing Cash Flow | $312M | $-464M | $-744M | $-790M | $-1.65B | $-400M | $-293M | $1.14B | $-1.06B | $-206M | $-1.42B | $-536M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | $0 | $689M | $123M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | $689M | $123M | |
| Stock Issued | · | · | · | · | · | · | · | · | $0 | $0 | $373M | $0 | |
| Stock Repurchased | $1.00B | $1.00B | $0 | $400M | $128M | $606M | $47M | $0 | $0 | · | $0 | $0 | |
| Net Stock Activity | $-1.00B | $-1.00B | $0 | $-400M | $-128M | $-606M | $-47M | · | $0 | $0 | $373M | $0 | |
| Financing Cash Flow | $-170M | $-347M | $-58M | $-441M | $-183M | $217M | $-559M | $-1.19B | $636M | $19M | $1.08B | $79M | |
| Net Change in Cash | $-393M | $-167M | $860M | $-458M | $283M | $1.72B | $-418M | $-364M | $378M | $486M | $790M | $603M | |
| Taxes Paid | $275M | $379M | $405M | $340M | $235M | $321M | $239M | $240M | $7M | $153M | $197M | $30M | |
| Free Cash Flow | $-636M | $544M | $1.58B | $682M | $2.04B | $1.82B | $370M | $-344M | $718M | $497M | · | · | |
| Levered FCF | · | · | $1.50B | $600M | $1.95B | $1.74B | $304M | $-425M | $619M | $471M | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 12.8% | 13.7% | 13.3% | 9.1% | 9.4% | 10.6% | · | |
| Operating Margin | 1.7% | 4.2% | 4.6% | 3.7% | 3.7% | 5.5% | 6.2% | 6.0% | -2.8% | 1.7% | 2.7% | 2.0% | |
| Net Margin | 1.0% | 2.9% | 3.2% | 2.5% | 2.4% | 3.5% | 4.4% | 3.7% | -2.6% | 0.29% | 1.0% | 0.64% | |
| Pretax Margin | 1.3% | 3.9% | 4.3% | 3.3% | 3.1% | 5.0% | 5.8% | 5.3% | -3.1% | 1.1% | 2.3% | 1.4% | |
| EBITDA Margin | 2.1% | 4.7% | 5.1% | 4.2% | 4.1% | 6.0% | 6.7% | 6.7% | -1.9% | 2.7% | 3.6% | 3.4% | |
| ROA | 3.0% | 7.7% | 8.0% | 6.5% | 6.1% | 8.2% | 10.6% | 9.0% | -6.4% | 0.74% | 2.6% | 1.7% | |
| ROE | 10.9% | 25.4% | 27.0% | 26.4% | 25.6% | 33.2% | 40.9% | 47.4% | -34.3% | 3.2% | 11.1% | 6.5% | |
| ROIC | 8.0% | 17.1% | 18.3% | 17.0% | 16.0% | 17.9% | 24.8% | 30.0% | -17.5% | 2.4% | 8.6% | 8.8% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.6 | 1.5 | 1.5 | 1.4 | 1.6 | 1.8 | 1.5 | 1.4 | 1.3 | 1.4 | 1.5 | |
| Quick Ratio | 1.6 | 1.6 | 1.5 | 1.4 | 1.4 | 1.6 | 1.8 | 1.4 | 1.2 | 1.2 | 1.2 | 1.5 | |
| Debt / Equity | 0.9 | 0.7 | 0.5 | 0.7 | 0.8 | 1.0 | 0.6 | 0.6 | 1.0 | 1.0 | 0.3 | 0.0 | |
| LT Debt / Equity | 0.9 | 0.7 | 0.5 | 0.7 | 0.8 | 1.0 | 0.6 | 0.6 | 1.0 | 0.7 | · | · | |
| Interest Coverage | · | · | 14.4 | 10.7 | 8.5 | 10.6 | 12.0 | 9.8 | -4.7 | 3.0 | 5.9 | 3.4 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.9 | 2.7 | 2.5 | 2.6 | 2.6 | 2.4 | 2.4 | 2.4 | 2.5 | 2.5 | 2.6 | 2.6 | |
| Receivables Turnover | 13.3 | 12.7 | 12.6 | 14.3 | 14.4 | 12.6 | 12.3 | 17.2 | 21.6 | 22.6 | 23.8 | 21.6 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $79.78 | $80.29 | $72.67 | $51.10 | · | $35.53 | $31.61 | $26.56 | $22.28 | $28.93 | $27.80 | $20.32 | |
| Revenue / Share | $858.71 | $704.51 | $586.44 | $546.56 | $473.91 | $323.72 | $262.95 | $283.63 | $355.05 | $317.54 | $253.18 | $199.97 | |
| Cash Flow / Share | $-10.11 | $11.16 | $28.61 | $13.21 | $36.16 | $31.50 | $6.67 | $-4.71 | $14.36 | $12.02 | $20.09 | $21.93 | |
| Cash / Share | $83.29 | $83.25 | $83.59 | $69.07 | · | $70.41 | $39.55 | $45.58 | $53.10 | $49.46 | $41.59 | $30.95 | |
| EPS (TTM) | $8.92 | $20.42 | $18.77 | $13.55 | $11.25 | $11.23 | $11.47 | $10.61 | $-9.07 | $0.92 | $2.58 | $1.29 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.8% | 19.3% | 6.6% | 15.1% | 43.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.4% | 13.5% | 20.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 18.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -56.3% | 8.8% | 38.5% | 20.4% | 0.18% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -13.0% | 22.0% | 18.7% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -4.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -60.0% | 8.1% | 37.8% | 20.2% | -2.1% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -15.8% | 21.4% | 17.5% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -6.9% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $45.43B | $40.65B | $34.07B | $31.97B | $27.77B | $19.42B | $16.83B | $18.89B | $19.88B | $17.78B | $14.18B | $9.67B | |
| Net Income TTM | $472M | $1.18B | $1.09B | $792M | $659M | $673M | $737M | $707M | $-512M | $52M | $143M | $62M | |
| Market Cap | $8.85B | $16.30B | $20.96B | $19.15B | · | $12.55B | $8.41B | $7.21B | $4.60B | $3.09B | $3.37B | $2.66B | |
| Enterprise Value | $4.36B | $10.23B | $14.03B | $13.82B | · | $8.65B | $5.25B | $3.72B | $209M | $161M | $-314M | $104M | |
| P/E | 19.5 | 14.3 | 19.2 | 24.4 | 28.3 | 18.9 | 11.8 | 11.0 | -8.5 | 59.0 | 23.3 | 41.5 | |
| P/S | 0.2 | 0.4 | 0.6 | 0.6 | · | 0.6 | 0.5 | 0.4 | 0.2 | 0.2 | 0.2 | 0.3 | |
| P/B | 2.2 | 3.6 | 5.0 | 6.5 | · | 6.0 | 4.3 | 4.4 | 3.4 | 1.9 | 2.2 | 2.6 | |
| P / Tangible Book | 4.7 | 6.4 | 7.6 | 12.2 | · | 10.9 | · | · | · | · | · | · | |
| P / Cash Flow | -16.5 | 25.3 | 12.6 | 24.8 | · | 6.6 | 19.7 | -22.9 | 5.7 | 4.6 | 3.0 | 2.5 | |
| P / FCF | -13.9 | 30.0 | 13.3 | 28.1 | · | 6.9 | 22.7 | -20.9 | 6.4 | 6.2 | · | · | |
| EV / EBITDA | 4.5 | 5.4 | 8.0 | 10.2 | · | 7.4 | 4.6 | 3.0 | -0.6 | 0.3 | -0.6 | 0.3 | |
| EV / FCF | -6.9 | 18.8 | 8.9 | 20.3 | · | 4.8 | 14.2 | -10.8 | 0.3 | 0.3 | · | · | |
| EV / Revenue | 0.1 | 0.3 | 0.4 | 0.4 | · | 0.4 | 0.3 | 0.2 | 0.0 | 0.0 | -0.0 | 0.0 | |
| Earnings Yield | 5.1% | 7.0% | 5.2% | 4.1% | 3.5% | 5.3% | 8.5% | 9.1% | -11.8% | 1.7% | 4.3% | 2.4% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.87B | $10.80B | $11.38B | $11.48B | $11.43B | $11.15B | $10.50B | $10.34B | $9.88B | $9.93B | $9.05B | $8.55B | $8.33B | $8.15B | $8.22B | $7.93B | |
| Cost of Revenue | $9.44B | $9.27B | $10.14B | $10.04B | $9.83B | $9.48B | $9.00B | $8.64B | $8.37B | $8.41B | $7.45B | $7.31B | $7.04B | $6.87B | $6.99B | $6.75B | |
| SG&A Expense | $724M | $779M | $795M | $729M | $711M | $774M | $665M | $676M | $691M | $711M | $645M | $608M | $618M | $591M | $629M | $560M | |
| Operating Expenses | $10.73B | $10.71B | $11.54B | $11.34B | $11.05B | $10.71B | $10.12B | $9.87B | $9.45B | $9.51B | $8.73B | $8.19B | $7.88B | $7.69B | $8.12B | $7.59B | |
| Operating Income | $145M | $83M | $-162M | $137M | $373M | $433M | $380M | $467M | $434M | $426M | $316M | $359M | $443M | $455M | $105M | $335M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $27M | · | $27M | $27M | $28M | · | $28M | |
| Interest Income | · | · | · | · | · | · | · | $20M | $21M | $22M | · | $20M | $19M | $21M | · | $19M | |
| Other Non-op | · | · | · | · | · | · | · | · | $-28M | $-27M | · | $-27M | $-27M | $-28M | · | $-28M | |
| Pretax Income | $91M | $29M | $-214M | $88M | $325M | $390M | $346M | $438M | $406M | $399M | $289M | $332M | $416M | $427M | $78M | $307M | |
| Income Tax | $31M | $15M | $-54M | $9M | $70M | $92M | $95M | $112M | $105M | $98M | $73M | $87M | $107M | $106M | $22M | $77M | |
| Net Income | $60M | $14M | $-160M | $79M | $255M | $298M | $251M | $326M | $301M | $301M | $216M | $245M | $309M | $321M | $56M | $230M | |
| EPS (Basic) | $1.19 | $0.27 | $-2.80 | $1.51 | $4.75 | $5.47 | $4.46 | $5.67 | $5.18 | $5.21 | $3.72 | $4.24 | $5.37 | $5.58 | $0.98 | $4.00 | |
| EPS (Diluted) | $1.19 | $0.27 | $-2.79 | $1.51 | $4.75 | $5.45 | $4.43 | $5.65 | $5.17 | $5.17 | $3.69 | $4.21 | $5.35 | $5.52 | $0.96 | $3.95 | |
| Shares (Basic) | 51,100,000 | 50,900,000 | · | 52,500,000 | 53,600,000 | 54,600,000 | · | 57,600,000 | 58,100,000 | 57,900,000 | · | 57,800,000 | 57,700,000 | 57,500,000 | · | 57,600,000 | |
| Shares (Diluted) | 51,300,000 | 51,000,000 | · | 52,500,000 | 53,700,000 | 54,800,000 | · | 57,700,000 | 58,200,000 | 58,300,000 | · | 58,100,000 | 57,900,000 | 58,000,000 | · | 58,300,000 | |
| EBITDA | $145M | $122M | · | $137M | $373M | $481M | · | $467M | $434M | $471M | · | $359M | $443M | $499M | · | $335M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.99B | $5.31B | $4.25B | $4.22B | $4.50B | $4.86B | $4.66B | $4.73B | $4.35B | $4.51B | $4.85B | $5.57B | $4.91B | $4.55B | $4.01B | $4.24B | |
| Short-term Investments | $3.93B | $3.94B | $4.01B | $4.23B | $4.31B | $4.44B | $4.33B | $4.48B | $4.35B | $4.42B | · | $4.11B | $3.89B | $3.81B | · | $3.64B | |
| Receivables | $3.48B | $3.42B | $3.53B | $3.52B | $3.87B | $3.49B | $3.30B | $3.26B | $3.23B | $3.35B | · | $2.46B | $2.38B | $2.54B | · | $2.22B | |
| Prepaid Expense | $528M | $655M | $655M | $590M | $438M | $472M | $487M | $408M | $399M | $381M | · | $332M | $260M | $259M | · | $391M | |
| Current Assets | $12.93B | $13.33B | $12.44B | $12.55B | $13.11B | $13.26B | $12.77B | $12.88B | $12.33B | $12.67B | · | $12.47B | $11.44B | $11.16B | · | $10.49B | |
| PP&E (Gross) | · | · | $1.11B | · | · | · | $1.03B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $875M | · | · | · | $806M | · | · | · | · | · | · | · | · | · | |
| Goodwill | · | · | $1.96B | · | · | · | $1.67B | · | · | · | $1.24B | · | · | · | $1.11B | · | |
| Intangibles | · | · | $237M | · | · | · | $267M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $140M | $146M | $147M | $142M | $148M | $163M | $138M | $132M | $136M | $134M | · | $125M | $118M | $119M | · | $186M | |
| Total Assets | $16.00B | $16.39B | $15.56B | $15.70B | $16.21B | $16.39B | $15.63B | $15.76B | $15.19B | $15.51B | · | $14.87B | $13.66B | $13.37B | · | $12.79B | |
| Accounts Payable | $1.14B | $1.16B | $1.09B | $1.12B | $1.11B | $1.12B | $1.33B | $1.22B | $973M | $1.11B | · | $1.09B | $857M | $787M | · | $818M | |
| Current Liabilities | $7.70B | $8.19B | $7.37B | $7.48B | $7.88B | $8.15B | $7.90B | $8.34B | $7.84B | $8.51B | · | $8.49B | $7.54B | $7.61B | · | $7.24B | |
| Capital Leases | · | · | $56M | · | · | · | $68M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $179M | $176M | $173M | $174M | $167M | $155M | $120M | $122M | $122M | $124M | · | $121M | $122M | $88M | · | $118M | |
| Total Liabilities | $11.83B | $12.31B | $11.49B | $11.51B | $11.61B | $12.08B | $11.13B | $10.99B | $10.34B | $11.02B | · | $10.99B | $10.04B | $10.08B | · | $9.75B | |
| Total Debt | $3.77B | $3.77B | · | $3.66B | $3.38B | $3.57B | · | $2.33B | $2.18B | $2.18B | · | $2.18B | $2.18B | $2.18B | · | $2.17B | |
| Retained Earnings | $3.68B | $3.62B | $3.60B | $3.76B | $4.16B | $3.90B | $4.09B | $4.33B | $4.49B | $4.19B | · | $3.67B | $3.43B | $3.12B | · | $2.94B | |
| AOCI | $-16M | $-7M | $15M | $9M | $-10M | $-28M | $-57M | $-9M | $-85M | $-85M | · | $-165M | $-146M | $-125M | · | $-185M | |
| Stockholders' Equity | $4.17B | $4.08B | $4.07B | $4.19B | $4.60B | $4.31B | $4.50B | $4.77B | $4.84B | $4.49B | $4.21B | $3.88B | $3.62B | $3.29B | $2.96B | $3.04B | |
| Liabilities + Equity | $16.00B | $16.39B | $15.56B | $15.70B | $16.21B | $16.39B | $15.63B | $15.76B | $15.19B | $15.51B | · | $14.87B | $13.66B | $13.37B | · | $12.79B | |
| Shares Outstanding | 52,000,000 | 52,000,000 | 51,000,000 | 51,000,000 | 54,000,000 | 54,000,000 | 56,000,000 | 57,000,000 | 59,000,000 | 59,000,000 | 58,000,000 | 58,000,000 | 58,000,000 | 58,000,000 | 58,000,000 | 58,000,000 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $40M | $39M | $44M | $45M | $58M | $48M | $48M | $47M | $46M | $45M | $43M | $42M | $42M | $44M | $47M | $45M | |
| Stock-based Comp | $26M | $33M | $20M | $-3M | $3M | $27M | $18M | $30M | $32M | $36M | $27M | $33M | $30M | $25M | $23M | $23M | |
| Other Non-cash | · | $996M | · | · | · | $-183M | · | · | · | $-168M | · | · | · | $526M | · | · | |
| Operating Cash Flow | $-294M | $1.08B | $-298M | $-125M | $-302M | $190M | $-224M | $873M | $-219M | $214M | $-690M | $949M | $487M | $916M | $-212M | $254M | |
| CapEx | $30M | $27M | $-1M | $38M | $42M | $22M | $11M | $35M | $27M | $27M | $-5M | $26M | $31M | $32M | $10M | $31M | |
| Investing Cash Flow | $-30M | $11M | $230M | $77M | $128M | $-123M | $19M | $-48M | $53M | $-488M | $-25M | $-280M | $-137M | $-302M | $148M | $-347M | |
| Stock Repurchased | $0 | $0 | $0 | $500M | $0 | $500M | $500M | $500M | $0 | $0 | $0 | $0 | · | · | $200M | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $-500M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-4M | $-20M | $92M | $-220M | $-189M | $147M | $67M | $-364M | $12M | $-62M | $3M | $-6M | $10M | $-65M | $-183M | $10M | |
| Net Change in Cash | $-328M | $1.07B | $24M | $-268M | $-363M | $214M | $-138M | $461M | $-154M | $-336M | $-712M | $663M | $360M | $549M | $-247M | $-83M | |
| Free Cash Flow | · | $1.05B | · | · | · | $168M | · | · | · | $187M | · | · | · | $884M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $167M | · | · | · | $863M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 1.3% | 0.77% | · | 1.2% | 3.3% | 3.9% | · | 4.5% | 4.4% | 4.3% | · | 4.2% | 5.3% | 5.6% | · | 4.2% | |
| Net Margin | 0.55% | 0.13% | · | 0.69% | 2.2% | 2.7% | · | 3.1% | 3.0% | 3.0% | · | 2.9% | 3.7% | 3.9% | · | 2.9% | |
| Pretax Margin | 0.84% | 0.27% | · | 0.77% | 2.8% | 3.5% | · | 4.2% | 4.1% | 4.0% | · | 3.9% | 5.0% | 5.2% | · | 3.9% | |
| EBITDA Margin | 1.3% | 1.1% | · | 1.2% | 3.3% | 4.3% | · | 4.5% | 4.4% | 4.7% | · | 4.2% | 5.3% | 6.1% | · | 4.2% | |
| ROA | 0.37% | 0.09% | · | 0.50% | 1.6% | 1.9% | · | 2.1% | 2.1% | 2.1% | · | 1.8% | 2.4% | 2.5% | · | 1.9% | |
| ROE | 1.4% | 0.33% | · | 1.8% | 5.4% | 6.8% | · | 7.5% | 7.1% | 7.7% | · | 7.1% | 9.6% | 10.6% | · | 8.3% | |
| ROIC | 1.2% | 0.51% | · | 1.6% | 3.7% | 4.2% | · | 4.9% | 4.6% | 4.8% | · | 4.4% | 5.7% | 6.3% | · | 4.8% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.6 | · | 1.7 | 1.7 | 1.6 | · | 1.5 | 1.6 | 1.5 | · | 1.5 | 1.5 | 1.5 | · | 1.4 | |
| Quick Ratio | 1.6 | 1.5 | · | 1.6 | 1.6 | 1.6 | · | 1.5 | 1.5 | 1.4 | · | 1.4 | 1.5 | 1.4 | · | 1.4 | |
| Debt / Equity | 0.9 | 0.9 | · | 0.9 | 0.7 | 0.8 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | |
| LT Debt / Equity | 0.9 | 0.9 | · | 0.9 | 0.7 | 0.8 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 15.8 | · | 13.3 | 16.4 | 16.2 | · | 12.0 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.6 | 0.6 | 0.6 | · | 0.7 | |
| Receivables Turnover | 3.0 | 3.1 | · | 3.4 | 3.2 | 3.3 | · | 3.6 | 3.5 | 3.4 | · | 3.7 | 3.6 | 3.5 | · | 3.8 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $80.21 | $78.46 | · | $82.18 | $85.24 | $79.81 | · | $83.68 | $82.08 | $76.15 | · | $66.88 | $62.43 | $56.69 | · | $52.43 | |
| Revenue / Share | $211.97 | $211.69 | · | $218.61 | $212.79 | $203.41 | · | $179.20 | $169.76 | $170.34 | · | $147.13 | $143.82 | $140.50 | · | $135.97 | |
| Cash Flow / Share | · | $21.22 | · | · | · | $3.47 | · | · | · | $3.67 | · | · | · | $15.79 | · | · | |
| Cash / Share | $95.87 | $102.19 | · | $82.76 | $83.31 | $89.93 | · | $83.02 | $73.80 | $76.49 | · | $95.95 | $84.66 | $78.52 | · | $73.14 | |
| EPS (TTM) | $0.18 | $3.74 | · | $16.14 | $20.28 | $20.70 | · | $19.68 | $18.24 | $18.42 | · | $16.04 | $15.78 | $14.68 | · | $14.33 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $44.52B | $45.08B | · | $44.55B | $43.41B | $41.87B | · | $39.20B | $37.41B | $35.85B | · | $33.25B | $32.63B | $32.35B | · | $31.16B | |
| Net Income TTM | $-7M | $188M | · | $883M | $1.13B | $1.18B | · | $1.14B | $1.06B | $1.07B | · | $931M | $916M | $855M | · | $839M | |
| Market Cap | $11.89B | $6.93B | · | $9.76B | $16.09B | $17.79B | · | $19.64B | $17.54B | $24.24B | · | $19.02B | $17.47B | $15.51B | · | $19.13B | |
| Enterprise Value | $6.75B | $1.45B | · | $4.98B | $10.65B | $12.07B | · | $12.76B | $11.02B | $17.48B | · | $11.52B | $10.85B | $9.33B | · | $13.42B | |
| P/E | 1270.6 | 35.6 | · | 11.9 | 14.7 | 15.9 | · | 17.5 | 16.3 | 22.3 | · | 20.4 | 19.1 | 18.2 | · | 23.0 | |
| P/S | 0.3 | 0.2 | · | 0.2 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.7 | · | 0.6 | 0.5 | 0.5 | · | 0.6 | |
| P/B | 2.9 | 1.7 | · | 2.3 | 3.5 | 4.1 | · | 4.1 | 3.6 | 5.4 | · | 4.9 | 4.8 | 4.7 | · | 6.3 | |
| P / Tangible Book | 2.9 | 1.7 | · | 2.3 | 3.5 | 4.1 | · | 4.1 | 3.6 | 5.4 | · | 4.9 | 4.8 | 4.7 | · | 6.3 | |
| P / Cash Flow | · | 6.4 | · | · | · | 93.6 | · | · | · | 113.3 | · | · | · | 16.9 | · | · | |
| EV / Revenue | 0.2 | 0.0 | · | 0.1 | 0.2 | 0.3 | · | 0.3 | 0.3 | 0.5 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | |
| Earnings Yield | 0.08% | 2.8% | · | 8.4% | 6.8% | 6.3% | · | 5.7% | 6.1% | 4.5% | · | 4.9% | 5.2% | 5.5% | · | 4.3% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $45.43B | $40.65B | $34.07B | $31.97B | $27.77B |
| Betriebsgewinnmarge % | 1.7% | 4.2% | 4.6% | 3.7% | 3.7% |
| Nettoergebnis | $472M | $1.18B | $1.09B | $792M | $659M |
| Verwässerte EPS | $8.92 | $20.42 | $18.77 | $13.55 | $11.25 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.9 | 0.7 | 0.5 | 0.7 | 0.8 |
| Liquiditätsgrad | 1.7 | 1.6 | 1.5 | 1.5 | 1.4 |
| Quick Ratio | 1.6 | 1.6 | 1.5 | 1.4 | 1.4 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-636M | $544M | $1.58B | $682M | $2.04B |
Institutionelle Eigentümer (13F) 673 Einreicher · $13.8B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 159 (+18 vs. Vorquartal) | 68 (-75 vs. Vorquartal) | 219 (+23 vs. Vorquartal) | 181 (+8 vs. Vorquartal) | +1.1M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $1.503.052.088 | 6.572.156 | 10,91% | Aktien |
| VANGUARD GROUP INC | $1.055.736.837 | 6.083.536 | 7,66% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $806.903.452 | 3.560.601 | 5,86% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $638.128.574 | 2.790.243 | 4,63% | Aktien |
| Capital World Investors | $586.138.203 | 2.562.913 | 4,26% | Aktien |
| Lingotto Investment Management LLP | $574.377.763 | 2.511.490 | 4,17% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $538.648.191 | 2.355.261 | 3,91% | Aktien |
| FMR LLC | $427.964.063 | 1.871.290 | 3,11% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $427.014.918 | 1.867.140 | 3,10% | Aktien |
| STATE STREET CORP | $401.475.303 | 1.755.467 | 2,91% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $318.659.985 | 1.393.338 | 2,31% | Aktien |
| GOLDMAN SACHS GROUP INC | $298.810.862 | 1.306.563 | 2,17% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $289.810.242 | 1.267.207 | 2,10% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $289.611.501 | 1.266.338 | 2,10% | Aktien |
| Capital Research Global Investors | $249.797.804 | 1.092.251 | 1,81% | Aktien |
| MORGAN STANLEY | $230.316.927 | 1.007.068 | 1,67% | Aktien |
| HARRIS ASSOCIATES L P | $218.980.250 | 957.500 | 1,59% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $204.005.369 | 891.772 | 1,48% | Aktien |
| 8 KNOTS MANAGEMENT, LLC | $198.942.438 | 1.146.378 | 1,44% | Aktien |
| MANNING & NAPIER ADVISORS LLC | $152.338.582 | 663.669 | 1,11% | Aktien |
| UBS Group AG | $142.749.967 | 624.180 | 1,04% | Aktien |
| Long Focus Capital Management, LLC | $139.507.000 | 610.000 | 1,01% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $131.512.792 | 575.045 | 0,95% | Aktien |
| TWO SIGMA ADVISERS, LP | $116.582.437 | 671.790 | 0,85% | Aktien |
| Invesco Ltd. | $116.332.600 | 508.669 | 0,84% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $115.548.617 | 505.241 | 0,84% | Aktien |
| NORTHERN TRUST CORP | $88.292.838 | 386.064 | 0,64% | Aktien |
| NORGES BANK | $87.054.426 | 380.649 | 0,63% | Aktien |
| Bank of New York Mellon Corp | $86.138.019 | 376.642 | 0,63% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $82.789.400 | 362.000 | 0,60% | Verkaufsoption |
| BNP PARIBAS FINANCIAL MARKETS | $82.559.556 | 360.995 | 0,60% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $75.497.758 | 330.117 | 0,55% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $72.051.935 | 315.050 | 0,52% | Aktien |
| BANK OF AMERICA CORP /DE/ | $71.479.956 | 312.549 | 0,52% | Aktien |
| Amundi | $59.944.786 | 262.111 | 0,44% | Aktien |
| PRINCIPAL FINANCIAL GROUP INC | $57.795.692 | 252.714 | 0,42% | Aktien |
| Maple Rock Capital Partners Inc. | $55.642.710 | 243.300 | 0,40% | Aktien |
| Russell Investments Group, Ltd. | $53.133.740 | 232.165 | 0,39% | Aktien |
| INVESTMENT MANAGEMENT ASSOCIATES INC /ADV | $52.660.005 | 230.258 | 0,38% | Aktien |
| STATE OF MICHIGAN RETIREMENT SYSTEM | $51.238.863 | 224.044 | 0,37% | Aktien |
| D. E. Shaw & Co., Inc. | $47.575.775 | 208.027 | 0,35% | Aktien |
| CITIGROUP INC | $47.390.070 | 207.215 | 0,34% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $46.357.490 | 202.700 | 0,34% | Kaufoption |
| REDWOOD CAPITAL MANAGEMENT, LLC | $45.740.000 | 200.000 | 0,33% | Aktien |
| DEUTSCHE BANK AG\ | $45.272.766 | 197.957 | 0,33% | Aktien |
| INVESTMENT HOUSE LLC | $44.310.854 | 193.751 | 0,32% | Aktien |
| JANE STREET GROUP, LLC | $43.224.300 | 189.000 | 0,31% | Verkaufsoption |
| Fiera Capital Corp | $43.130.075 | 188.588 | 0,31% | Aktien |
| Summit Street Capital Management, LLC | $41.630.489 | 182.031 | 0,30% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $41.211.511 | 180.199 | 0,30% | Aktien |
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Mary R. Molina Living Trust, Exempt Mary R. Molina Living Trust, Mary R. Molina Grantor Retained Annuity Trust 609/4, Mary R. Molina Grantor Retained Annuity Trust 609/7, Mary R. Molina Grantor Retained Annuity Trust 1209/3, Mary R. Molina Grantor Retained Annuity Trust 1209/4, Mary R. Molina Grantor Retained Annuity Trust 610/4, Mary R. Molina Grantor Retained Annuity Trust 610/5, Mary R. Molina Grantor Retained Annuity Trust 1210/4, Mary R. Molina Grantor Retained Annuity Trust 811/3, Mary R. Molina Grantor Retained Annuity Trust 812/3, Estate of Mary R. Molina, Dentino Family Trust, Curtis and Rosi Pedersen 2012 Trust, William Dentino, Curtis Pedersen ×3 Einreichungen | 23. Januar 2018 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 62 Insider · 25 Führungskräfte · 19 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Roman Kulich | Pres & CEO of Molina of MI | 22. August 2007 S | 5.734 | 0 | 0 | $0 |
| Gerald Landgraf | CEO/Pres of Molina of NM | 1. Juli 2005 A | · | 0 | 0 | $0 |
| Mark Lowell Keim | Chief Financial Officer | 1. März 2026 A | 83.251 | 0 | 0 | $0 |
| Joseph W White CPA | Former Chief Financial Officer | 6. Juni 2018 D | 48.390 | 0 | 0 | $0 |
| James Woys | Chief Operating Officer | 30. Juni 2026 A | 90.178 | 0 | 0 | $0 |
| Terry Bayer | Chief Operating Officer | 2. Februar 2018 D | 28.730 | 0 | 0 | $0 |
| Debra Bacon | EVP, Medicaid | 1. Juli 2026 F | 21.636 | 0 | 0 | $0 |
| Jeff D. Barlow | Chief Legal Officer | 30. Juni 2026 A | 67.313 | 0 | 1 | $-3.314.983 |
| Marc Russo | EVP, Health Plans | 7. August 2023 S | 37.093 | 0 | 0 | $0 |
| Pamela Sedmak | Executive Vice President | 1. März 2020 F | 8.846 | 0 | 0 | $0 |
| Lisa A Rubino | Senior Vice President | 1. März 2018 F | 25.084 | 0 | 0 | $0 |
| Keith Wilson | Chief Medical Officer | 30. Juni 2017 A | 29.441 | 0 | 0 | $0 |
| Amir Desai | Chief Information Officer | 16. August 2010 S | 16.782 | 0 | 0 | $0 |
| Mark L Andrews ESQ | Exec. VP, General Counsel | 1. Juli 2010 F | 51.006 | 0 | 0 | $0 |
| Mary Martha Bernadett MD | Exec. V.P., Research | 5. Dezember 2008 J | 50.000 | 0 | 0 | $0 |
| Stephen T O'Dell | Regional Vice President | 7. August 2008 F | 16.199 | 0 | 0 | $0 |
| Lillis Ann Koontz | Regional Vice President | 30. Juni 2008 A | 15.304 | 0 | 0 | $0 |
| George Kirk Olsen | VP, Molina Advantage | 29. Juni 2007 A | 7.822 | 0 | 0 | $0 |
| Michael M Siegel | Chief Medical Officer | 1. März 2007 A | 5.150 | 0 | 0 | $0 |
| Rick Click | Chief Information Officer | 1. März 2007 A | 8.500 | 0 | 0 | $0 |
| Harvey A Fein | VP, Internal Auditing | 1. März 2007 A | 8.713 | 0 | 0 | $0 |
| Joann Zarza-Garrido | VP, Compliance | 28. Februar 2007 S | 4.774 | 0 | 0 | $0 |
| William Bracciodieta | Former Chief Medical Officer | 16. Februar 2007 F | 5.000 | 0 | 0 | $0 |
| Sheila Shapiro | Exec. VP, Shared Services | 30. Dezember 2005 J | 12.564 | 0 | 0 | $0 |
| Jennings Patricia Dinsmore | VP Qual. Op. & Integration | 16. August 2004 S | 0 | 0 | 0 | $0 |
| Stephen H Lockhart | Direktor | 1. Oktober 2026 A | 4.688 | 0 | 0 | $0 |
| Richard M Schapiro | Direktor | 1. Oktober 2026 A | 12.615 | 0 | 1 | $-51.058 |
| Richard C Zoretic | Direktor | 1. Oktober 2026 A | 9.693 | 1 | 0 | $100.128 |
| Leo P Grohowski | Direktor | 1. Oktober 2026 A | 1.846 | 0 | 0 | $0 |
| Francis S Soistman JR | Direktor | 1. Oktober 2026 A | 1.211 | 0 | 0 | $0 |
| Dale B Wolf | Direktor | 1. Oktober 2026 A | 15.937 | 0 | 0 | $0 |
| Steven J Orlando | Direktor | 1. Oktober 2026 A | 18.271 | 0 | 0 | $0 |
| Ronna Romney | Direktor | 1. Oktober 2026 A | 18.173 | 0 | 1 | $-74.342 |
| Barbara L Brasier | Direktor | 1. Oktober 2026 A | 6.122 | 0 | 0 | $0 |
| Daniel Cooperman | Direktor | 1. April 2025 A | 6.383 | 0 | 0 | $0 |
| Garrey Carruthers | Direktor | 1. April 2021 A | 5.265 | 0 | 0 | $0 |
| Charles Z Fedak | Direktor | 1. April 2019 A | 19.092 | 0 | 0 | $0 |
| John C Molina | Direktor | 20. Februar 2018 S | 372.930 | 0 | 0 | $0 |
| Frank E Murray MD | Direktor | 1. Oktober 2017 A | 16.811 | 0 | 0 | $0 |
| Steven James | Direktor | 1. April 2016 A | 15.024 | 0 | 0 | $0 |
| John P Szabo JR | Direktor | 1. April 2015 A | 17.097 | 0 | 0 | $0 |
| Sally K Richardson | Direktor | 3. Mai 2012 A | 47.537 | 0 | 0 | $0 |
| Wayne B Lowell | Direktor | 10. Mai 2007 A | 10.011 | 0 | 0 | $0 |
| Ronald Cpa Dba Lossett | Direktor | 10. Februar 2004 A | · | 0 | 0 | $0 |
| MARY R MOLINA LIVING TRUST | 10%-Eigentümer | 14. Dezember 2009 J | 2.137.134 | 0 | 0 | $0 |
| MOLINA MARITAL TRUST | 10%-Eigentümer | 22. Juni 2006 S | 2.926.907 | 0 | 0 | $0 |
| Maurice Hebert | · | 14. Mai 2026 S | 12.815 | 0 | 1 | $-114.930 |
| Joseph M Zubretsky | · | 1. März 2026 A | 99.015 | 0 | 0 | $0 |
| Thomas L Tran | · | 24. Mai 2021 F | 29.775 | 0 | 0 | $0 |
| Norman Nichols | · | 8. August 2018 S | 47.415 | 0 | 0 | $0 |
| Harold Gooch | · | 30. Juni 2018 A | 7.063 | 0 | 0 | $0 |
| Mario J Molina MD | · | 11. Dezember 2017 S | 61.125 | 0 | 0 | $0 |
| James W Howatt | · | 19. März 2010 S | 34.081 | 0 | 0 | $0 |
| Curtis Pedersen | · | 5. November 2009 G | 1.200 | 0 | 0 | $0 |
| Josephine M Molina | · | 6. August 2008 J | 345.701 | 0 | 0 | $0 |
| Janet M Watt | · | 6. August 2008 J | 284.641 | 0 | 0 | $0 |
| Josephine M Battiste | · | 6. August 2008 J | 345.701 | 0 | 0 | $0 |
| Zarina Sparling | · | 21. Februar 2008 M | 9.380 | 0 | 0 | $0 |
| Mary R Molina | · | 27. September 2006 J | 0 | 0 | 0 | $0 |
| George S Goldstein PHD | · | 11. Mai 2006 M | 0 | 0 | 0 | $0 |
| Richard A Helmer MD | · | 30. Juni 2005 J | 1.908 | 0 | 0 | $0 |
| David W Erickson | · | 2. Dezember 2004 M | 0 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 73 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| SOVF · Elevation Series Trust | 4,23% | 18.894 NS | 31. Juli 2026 | N-PORT |
| RWK · Invesco Exchange-Traded Fund Trust … | 1,81% | 120.017 SH | 1. Oktober 2026 | Täglich |
| RFV · Invesco Exchange-Traded Fund Trust | 1,77% | 29.907 SH | 1. Oktober 2026 | Täglich |
| IHF · iShares Trust | 1,53% | 100.080 SH | 11. September 2026 | Täglich |
| VIOV · VANGUARD ADMIRAL FUNDS | 1,28% | 110.553 SH | 19. August 2026 | Täglich |
| BSJS · Invesco Exchange-Traded Self-Indexe… | 0,76% | 5.983.000 | 1. Oktober 2026 | Täglich |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,64% | 182.154 SH | 19. August 2026 | Täglich |
| FFLV · FIDELITY COVINGTON TRUST | 0,41% | 343 NS | 31. Juli 2026 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0,40% | 6.790 NS | 31. Juli 2026 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,33% | 7.103 SH | 1. Oktober 2026 | Täglich |
| DFAT · Dimensional ETF Trust | 0,27% | 198.247 NS | 31. Juli 2026 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0,26% | 8.610 NS | 31. Juli 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,25% | 758.589 SH | 19. August 2026 | Täglich |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,22% | 22.626 NS | 31. Juli 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0,22% | 765 NS | 31. Juli 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0,20% | 3.918 NS | 31. Juli 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,18% | 156.577 SH | 19. August 2026 | Täglich |
| ESML · iShares Trust | 0,17% | 23.899 SH | 11. September 2026 | Täglich |
| IYH · iShares Trust | 0,17% | 30.059 SH | 11. September 2026 | Täglich |
| DFSV · Dimensional ETF Trust | 0,16% | 67.624 NS | 31. Juli 2026 | N-PORT |
| ISCG · iShares Trust | 0,16% | 7.446 SH | 11. September 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,15% | 24.870 NS | 31. Juli 2026 | N-PORT |
| SMMD · iShares Trust | 0,14% | 27.458 SH | 11. September 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,14% | 1.195.007 SH | 19. August 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,13% | 597.850 SH | 19. August 2026 | Täglich |
| IWS · iShares Trust | 0,10% | 77.233 SH | 11. September 2026 | Täglich |
| WSML · iShares Trust | 0,10% | 3.305 SH | 11. September 2026 | Täglich |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,10% | 4.920 SH | 1. Oktober 2026 | Täglich |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 3.768 SH | 1. Oktober 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,09% | 68.863 NS | 31. Juli 2026 | N-PORT |
| IWR · iShares Trust | 0,08% | 210.604 SH | 11. September 2026 | Täglich |
| PRF · Invesco Exchange-Traded Fund Trust | 0,07% | 35.013 SH | 1. Oktober 2026 | Täglich |
| EMGF · iShares, Inc. | 0,06% | 15.805 SH | 11. September 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,05% | 1.409 NS | 31. Juli 2026 | N-PORT |
| EMXC · iShares, Inc. | 0,05% | 162.911 SH | 11. September 2026 | Täglich |
| DFSU · Dimensional ETF Trust | 0,04% | 5.157 NS | 31. Juli 2026 | N-PORT |
| VEGN · ETF Series Solutions | 0,03% | 305 NS | 31. Juli 2026 | N-PORT |
| IUSV · iShares Trust | 0,03% | 45.470 SH | 11. September 2026 | Täglich |
| IEMG · iShares, Inc. | 0,03% | 689.771 SH | 11. September 2026 | Täglich |
| EEM · iShares, Inc. | 0,03% | 131.827 SH | 11. September 2026 | Täglich |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 31.058 SH | 19. August 2026 | Täglich |
| IWD · iShares Trust | 0,03% | 114.206 SH | 11. September 2026 | Täglich |
| DFUV · Dimensional ETF Trust | 0,03% | 20.443 NS | 31. Juli 2026 | N-PORT |
| DYNF · BlackRock ETF Trust | 0,03% | 52.472 SH | 11. September 2026 | Täglich |
| TILT · FlexShares Trust | 0,02% | 2.686 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,02% | 1.655.258 SH | 19. August 2026 | Täglich |
| VWO · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,02% | 868.836 SH | 19. August 2026 | Täglich |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,02% | 8.548 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,02% | 4.354 SH | 19. August 2026 | Täglich |
| ESGV · VANGUARD WORLD FUND | 0,02% | 11.634 SH | 19. August 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,02% | 45.023 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,02% | 2.946 NS | 31. Juli 2026 | N-PORT |
| IXUS · iShares Trust | 0,02% | 126.782 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,01% | 14.718 SH | 11. September 2026 | Täglich |
| IWB · iShares Trust | 0,01% | 35.396 SH | 11. September 2026 | Täglich |
| IYY · iShares Trust | 0,01% | 2.168 SH | 11. September 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,01% | 15.184 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,01% | 67.059 SH | 11. September 2026 | Täglich |
| DFAU · Dimensional ETF Trust | 0,01% | 8.285 NS | 31. Juli 2026 | N-PORT |
| NEAR · iShares U.S. ETF Trust | 0,01% | 531.000 SH | 11. September 2026 | Täglich |
| VOXP · Advisors Series Trust | 0,01% | 3 NS | 31. Juli 2026 | N-PORT |
| ACWX · iShares Trust | 0,01% | 16.724 SH | 11. September 2026 | Täglich |
| VXUS · VANGUARD STAR FUNDS | 0,01% | 910.737 SH | 19. August 2026 | Täglich |
| VEU · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 145.760 SH | 19. August 2026 | Täglich |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 89.282 SH | 19. August 2026 | Täglich |
| VYMI · VANGUARD WHITEHALL FUNDS | 0,01% | 68.906 SH | 19. August 2026 | Täglich |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,01% | 2.303 SH | 1. Oktober 2026 | Täglich |
| ACWI · iShares Trust | 0,00% | 8.307 SH | 11. September 2026 | Täglich |
| IJH · iShares Trust | · | 1.828.162 SH | 11. September 2026 | Täglich |
| IJJ · iShares Trust | · | 265.658 SH | 21. August 2026 | Täglich |
| ISCB · iShares Trust | · | 2.352 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 6.481 SH | 11. September 2026 | Täglich |
| SMMV · iShares Trust | · | 4.872 SH | 1. September 2026 | Täglich |
MOH Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
12-Monats-Kursziel
17 Analysten · 2026-09-30Mittelwert-Ziel $209.12 +10,3%
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | · |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | · |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | · |
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | · |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| CLOV | · | -5.1 | 40.3% | -4.5% | -26.2% | · |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
| ALHC | $4.03B | · | 46.1% | -0.02% | -0.52% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.